Truist Financial’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.41M Sell
17,402
-1,625
-9% -$431K 0.01% 697
2026
Q1
$2.09M Sell
19,027
-19,576
-51% -$2.79M ﹤0.01% 1299
2025
Q4
$6.42M Buy
38,603
+3,541
+10% +$592K 0.01% 754
2025
Q3
$6.87M Buy
35,062
+25,585
+270% +$4.21M 0.01% 744
2025
Q2
$857K Sell
9,477
-3,360
-26% -$265K ﹤0.01% 1672
2025
Q1
$766K Sell
12,837
-1,680
-12% -$155K ﹤0.01% 1649
2024
Q4
$1.92M Buy
14,517
+3,244
+29% +$304K ﹤0.01% 1245
2024
Q3
$591K Buy
11,273
+5,439
+93% +$255K ﹤0.01% 1779
2024
Q2
$353K Buy
+5,834
New +$405K ﹤0.01% 2206

Other funds holding ALAB

Truist Financial's ALAB Position: Q2 2026 in Review

Truist Financial reduced its Astera Labs (ALAB) stake by 8.5% in Q2 2026, selling an estimated $431K and leaving 17,402 shares worth $8.41M. The position accounts for 0.01% of the portfolio, ranked #697.

Truist Financial first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Truist Financial held 17,402 shares of Astera Labs worth $8.41M as of Q2 2026.
  • Truist Financial sold 1,625 Astera Labs shares in Q2 2026, an estimated $431K.
  • Astera Labs made up 0.01% of Truist Financial's portfolio in Q2 2026, its #697 holding.
  • Truist Financial first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.